Given the recent developments in healthcare, supportingsafety and efficacy of peptide and affiliated macrocycle drugs, the industry ispresently witnessing an increase in discovery and development initiativesrelated to such therapeutic modalities.
Roots Analysis has announced the addition of “Peptidesand Macrocycle Drug Discovery: Services and PlatformsMarket, 2020-2030” report to its list of offerings.
The report features an extensive study on the currentmarket landscape and future of companies offering services for peptides andmacrocycle drug discovery operations. The study includes in-depth analyses,highlighting the capabilities of various service / technology providers engagedin this market. Amongst other elements, the report includes:
§ A detailed assessment of the current market landscape ofcompanies offering peptide and macrocycle drug discovery services
§ An insightful geographical benchmarking of the capabilitiesof companies of various sizes, highlighting the key focus areas, comparingtheir existing strengths both within and beyond their respective peer groups(based on geography and company size).
§ An in-depth analysis of peptide platform and libraryservice providers, featuring information on their company details, purpose ofthe platform, type of peptide manufactured and platform access model.
§ Profiles of peptides and macrocycle drug discovery serviceproviders, featuring information on the year of establishment, location ofheadquarters, peptide discovery service / platform portfolio, recentdevelopments, and an informed future outlook.
§ An analysis of the partnerships that have been establishedin the recent past, covering mergers and acquisitions, research collaborations,R&D agreements, licensing agreements (related to both technology platformsand service providers) and other form of collaborations.
§ An analysis of proprietary display technologies developedby different drug discovery technology providers, based on the 2X2 matrix.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Type of peptides
§ Syntheticpeptides
§ Biologicand recombinant peptides
§ Typeof discovery steps
§ Target identification and validation
§ Hit identification
§ Lead generation
§ Lead optimization
§ Therapeutic Area
§ Oncological disorders
§ Metabolic disorders
§ Cardiovascular disorders
§ Infectious diseases
§ Urological disorders
§ Endocrine disorders
§ CNS disorders
§ Other diseases
§ Company Size
§ Small companies
§ Mid-sized companies
§ Large and very large companies
§ Keygeographical regions
§ Europe
§ North America
§ Asia-Pacific and the Rest of the World
Keycompanies covered in the report
§ GenScript
§ JPT Peptide Technologies
§ CPC Scientific
§ IRBM
§ Creative Peptides
§ Pepscan
§ Interprotein
§ RA Pharmaceuticals
§ Pepticom
§ PeptiDream
§ Creative Biolabs
§ MeSCue-Janusys
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/immune-checkpoint-inhibitors/303.html
Other Recent Offerings
1. DNA-Encoded Libraries: Platforms andServices Market, 2020–2030
2. Antibody ContractManufacturingMarket, 2020 – 2030
3. Global AutoinjectorsMarket,2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
